Nonsteroidal anti-inflammatory drug-induced colopathy: an uncommon cause of positive immunochemical faecal occult blood test in the program for colorectal cancer screening

  • Brigita Smolović University of Montenegro, Faculty of Medicine, Podgorica, Montenegro
  • Ljiljana Vučković University of Montenegro, Faculty of Medicine, Podgorica, Montenegro
  • Sanja Borozan Department of Endocrinology, Clinical Center of Montenegro, Podgorica, Montenegro
  • Batrić Vukčevič Faculty of Medicine, University of Montenegro,Podgorica, Montenegro
Keywords: colorectal neoplasms;, diagnosis;, feces;, occult blood;, colonic diseases;, anti-inflammatory agents;, treatment outcome

Abstract


Introduction. Nonsteroidal anti-inflammatory drug-induced colopathy is an uncommon condition associated with the long-term use of enteric-coated and slow-release nonsteroidal anti-inflammatory drugs. This paper presents a case of colopathy showing no symptoms or signs, discovered by a positive immunochemical faecal occult blood test. Case report. Performed within the framework of the National Program for Screening of Colorectal Cancer, the immunochemical faecal occult blood test was positive in a 56-year-old female patient. The colonoscopy revealed three lesions in the right colon: one erosion-ulceration and two concentric "diaphragm-like" strictures passable by the endoscope. The patient reported that she had been taking diclofenac 100 mg twice a day for the past seven years. After withdrawing the offending drug, the second colonoscopy indicated a marked improvement in the colonic mucosa while the "diaphragm-like" strictures persisted. Conclusion. The cases of nonsteroidal anti-inflammatory drug-induced colopathy are likely to become more frequent. It would be, therefore, advisable to consider the long-term use of such drugs as being a possible factor that leads to mucosal injury, particularly in the right colon, as well as being a rare reason for a positive immunochemical faecal occult blood test.

Author Biography

Ljiljana Vučković, University of Montenegro, Faculty of Medicine, Podgorica, Montenegro

Department of Patology, Clinical Center of Montenegro, Podgorica, Montenegro

References

Munipalle PC, Garud T, Light D. Diaphragmatic disease of the colon: systematic review. Colorectal Dis 2013; 15(9): 1063‒9.

Tonolini M. Acute nonsteroidal anti-inflammatory drug-induced colitis. J Emerg Trauma Shock 2013; 6(4): 301–3.

Margolius DM, Cataldo TE. Nonsteroidal anti-inflammatory drug colopathy mimicking malignant masses of the colon: a report of three cases and review of the literature. Am Surg 2010; 76(11): 1282‒6.

Masannat AY, Harron M, Harinath G. Nonsteroidal anti-inflammatory drugs-associated colopathy. ANZ J Surg 2010;80(1‒2): 96–9.

Kurahara K, Matsumoto T, Iida M, Honda K, Yao T, Fujishima M. Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations. Am J Gastro-enterol 2001; 96(2): 473–80.

Mokhtare M, Valizadeh SM, Emadian O. Lower gastrointestinal bleeding due to Non-steroid Anti-inflammatory Drug-induced Colopathy Case Report and Literature Review. Middle East J Dig Dis 2013; 5(2): 107‒11.

Aftab AR, Donnellan F, Zeb F, Kevans D, Cullen G, Courtney G. NSAID-induced colopathy. A case series. J Gastrointestin Liver Dis 2010; 19(1): 89–91.

Püspök A, Kiener HP, Oberhuber G. Clinical, endoscopic, and histologic spectrum of nonsteroidal anti-inflammatory drug-induced lesions in the colon. Dis Colon Rectum 2000; 43(5): 685‒91.

El Hajj I, Hawchar M, Sharara A. NSAID-induced colopathy: case report and review of the literature. J Med Liban 2009; 57(4): 274‒6.

Fedak KM, Bernal A, Capshaw ZA, Gross S. Applying the Brad-ford Hill criteria in the 21st century: how data integration has changed causal inference in molecular epidemiology. Emerg Themes Epidemiol 2015; 12: 14.

Küttner Magalhães R, Ferreira JM, Pedroto I. Nonsteroidal anti-inflammatory drug (NSAID)-induced colopathy with dia-phragm-like strictures. J Gastrointestin Liver Dis 2014; 23(1): 9.

Belhekar MN, Taur SR, Munshi RP. A study of agreement be-tween the Naranjo algorithm and WHO-UMC criteria for causality assessment of adverse drug reactions. Indian J Phar-macol 2014; 46(1): 117‒20.

Published
2021/02/11
Section
Case report